28667 postsback to top
Posted 12 months ago
FDA: 'Z-Pak' antibiotics may damage heart health
FDA issued an ominous warning Tuesday cautioning about a potentially deadly cardiac complication associated with taking the prescription medicine. The warning follows a study published in the New England Journal of Medicine that compared the risks of cardiovascular deaths in patients who took the drug versus those who’ve taken other antibiotics including amoxicillin. The study says Z-Paks lead to higher rates of fatal heart rhythms.
The FDA says Z-Paks “can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm.”
That’s bad news for millions, as Zithromax is a popular choice of doctors because patients can take fewer doses over a shorter period than many other antibiotics. U.S. sales of the drug in 2011 exceeded $450 million, according to IMS Health.
Protect Your Kids From The 'Antibiotic Apocalypse'
Assessing the Risk
The FDA says “patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias.”
QT interval is a measure of time between the start of the Q and the end of the T waves that are part of the heart’s electrical cycle. These waves represent functions performed both the right and left ventricles.
The dangerous heart rhythm known as prolonged QT interval could indicate the ventricles are not working properly and could be an indication or a very fast heart rhythm that arises entirely in the lower chamber of the heart.
There are few symptoms of prolonged QT interval, but they may include a sudden loss of consciousness.
10 Top Health Risks For Men
Old Drug, New Label
The FDA has updated the drug's labels with information about the risk of prolonged QT interval and cautions doctors should take care when prescribing the drug to anyone with a history of heart disease or other heart issues. Pfizer issued an emailed statement that said most patients will not be affected by this label change and stressed other antibiotics in the same class have similar risks.
“Patients who are currently prescribed Zithromax should talk to their doctors or healthcare providers if they have questions regarding their treatment. Zithromax has had a well-established benefit risk profile for more than 20 years and continues to be an effective treatment option for patients all over the globe suffering from many types of bacterial infections,” Pfizer said in the statement.
Protecting Your Heart
The study suggests there would be 47 extra heart-related deaths per 1 million courses of treatment with Zithromax, compared with another antibiotic, amoxicillin, according to the Associated Press.
As with all medicines, the best way to protect your heart and overall health when taking Zithromax is with clear communication. Talk to your doctor about your current health and any possible side effects and drug interactions.